IN-Vitro Diagnostics: Next Generation Point-of-Care Testing

IN-Vitro Diagnostics: Next Generation Point-of-Care Testing

With budgets shrinking healthcare providers are under greater pressure than ever to deliver value, optimizing procedures and providing cost-and time-efficient care. Point-of-care testing can support this—equipping healthcare professionals with the information they need to make smart, on-the-spot medical decisions that improve workflow efficiency and, ultimately, patient outcomes.

As a leader in health technology, our goal at Philips is to revolutionize healthcare management. Where currently diagnostic blood testing is often carried out in a laboratory setting, we’re innovating to move beyond these walls and bring it near the patient—wherever they need it.

In 2016, we took our first step toward achieving this goal, launching the Minicare I-20 handheld system with cardiac troponin-l (cTnI) assay for suspected heart attack, delivering lab comparable results within just 10 minutes.

Philips is advancing toward our ultimate aim: to bring integrated and personalized care close to the patient, across the entire continuum of care

Now we have reached another important milestone with the launch of additional next generation Minicare in-vitro diagnostics systems:

• The Minicare C-300*—a clinical chemistry system that enables physicians to bypass the often time-consuming process of sending blood samples to a central or external laboratory for an extensive range of 27 chemistry parameters

• The Minicare H-300*—a hemostasis system that aids in the diagnosis and monitoring of coagulation abnormalities, giving the physicians crucial information in real time in critical care settings such as heavy blood trauma or massive surgery

• Minicare BNP*, an additional cardiac assay for the Minicare I-20, measuring the BNP (Brain Natriuretic Peptide) concentration in blood, to aid in the diagnosis of heart failure providing lab comparable test results within 10 minutes

By providing advanced clinical information through meaningful, cost-efficient and connected solutions, Philips is advancing toward our ultimate aim: to bring integrated and personalized care close to the patient, across the entire continuum of care.

With these advanced technologies and easy to use systems, Philips is helping to supply care providers with all the information they need to make decisions in the moments that matter, supporting them to streamline the patient journey and ensure that each individual gets the care they need.

Read Also

The Next Frontier in Precision Nutrition

The Next Frontier in Precision Nutrition

Ashlie L Burkart, MD, CM, Chief Scientific Officer, Germin8 Ventures
Clinical Integration and Stigma: On Treating Mental Health and Substance Use Disorders as Medical Illnesses

Clinical Integration and Stigma: On Treating Mental Health and Substance Use Disorders as Medical Illnesses

Gian Stefano Varbaro, MD MBA; Chief Medical Officer, Bergen New Bridge Medical Center, and Chief Medical Advisor, Bergen County, NJ
Improving Drug Shortage Management

Improving Drug Shortage Management

Ashley L. Pappas, PharmD, MHA Director of Pharmacy Medication Management and Optimization | Pharmacy Analytics and Outcomes Pharmacy Services, UNC Health Greg Norsten, PharmD PGY2 Health-System Pharmacy Administration and Leadership Resident, UNC Health
Take Advantage of Technology in Infection Prevention!

Take Advantage of Technology in Infection Prevention!

Kimberly Atrubin, Director, Infection Prevention, Tampa General Hospital
Take Advantage of Technology in Infection Prevention!

Take Advantage of Technology in Infection Prevention!

Kimberly Atrubin, Director, Infection Prevention, Tampa General Hospital
Enhancing Engagement to Mitigate Healthcare Risks

Enhancing Engagement to Mitigate Healthcare Risks

Lauren Prepchuk, Regional VP - Patient Transportation and Patient Observation, Crothall Healthcare